ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhalation Powder Budesonide Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-28F10035
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Inhalation Powder Budesonide Market Insights Forecast to 2028
BUY CHAPTERS

Global Inhalation Powder Budesonide Market Research Report 2025

Code: QYRE-Auto-28F10035
Report
July 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
TEVA
Mylan NV
Sandoz Inc
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla Ltd
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod

Inhalation Powder Budesonide Market Size

The global market for Inhalation Powder Budesonide was valued at US$ 1263 million in the year 2024 and is projected to reach a revised size of US$ 1815 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Inhalation Powder Budesonide Market

Inhalation Powder Budesonide Market

Inhalation Powder is white to off-white round particles, lightly pressed into powder, filled into a special multi-dose powder inhaler driven by inhalation airflow.
North American market for Inhalation Powder Budesonide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inhalation Powder Budesonide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inhalation Powder Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhalation Powder Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Powder Budesonide.
The Inhalation Powder Budesonide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhalation Powder Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalation Powder Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhalation Powder Budesonide Market Report

Report Metric Details
Report Name Inhalation Powder Budesonide Market
Accounted market size in year US$ 1263 million
Forecasted market size in 2031 US$ 1815 million
CAGR 5.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 100~200 Inhalation
  • Other
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inhalation Powder Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inhalation Powder Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Inhalation Powder Budesonide Market growing?

Ans: The Inhalation Powder Budesonide Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Inhalation Powder Budesonide Market size in 2031?

Ans: The Inhalation Powder Budesonide Market size in 2031 will be US$ 1815 million.

Who are the main players in the Inhalation Powder Budesonide Market report?

Ans: The main players in the Inhalation Powder Budesonide Market are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod

What are the Application segmentation covered in the Inhalation Powder Budesonide Market report?

Ans: The Applications covered in the Inhalation Powder Budesonide Market report are Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Other

What are the Type segmentation covered in the Inhalation Powder Budesonide Market report?

Ans: The Types covered in the Inhalation Powder Budesonide Market report are 100~200 Inhalation, Other

Recommended Reports

Inhaler Devices

Aerosol & Nebulizers

Steroids & Cannabinoids

1 Inhalation Powder Budesonide Market Overview
1.1 Product Definition
1.2 Inhalation Powder Budesonide by Type
1.2.1 Global Inhalation Powder Budesonide Market Value Comparison by Type (2024 VS 2031)
1.2.2 100~200 Inhalation
1.2.3 Other
1.3 Inhalation Powder Budesonide by Application
1.3.1 Global Inhalation Powder Budesonide Market Value by Application (2024 VS 2031)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Other
1.4 Global Inhalation Powder Budesonide Market Size Estimates and Forecasts
1.4.1 Global Inhalation Powder Budesonide Revenue 2020-2031
1.4.2 Global Inhalation Powder Budesonide Sales 2020-2031
1.4.3 Global Inhalation Powder Budesonide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhalation Powder Budesonide Market Competition by Manufacturers
2.1 Global Inhalation Powder Budesonide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhalation Powder Budesonide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhalation Powder Budesonide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhalation Powder Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhalation Powder Budesonide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalation Powder Budesonide, Product Type & Application
2.7 Global Key Manufacturers of Inhalation Powder Budesonide, Date of Enter into This Industry
2.8 Global Inhalation Powder Budesonide Market Competitive Situation and Trends
2.8.1 Global Inhalation Powder Budesonide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhalation Powder Budesonide Players Market Share by Revenue
2.8.3 Global Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalation Powder Budesonide Market Scenario by Region
3.1 Global Inhalation Powder Budesonide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhalation Powder Budesonide Sales by Region: 2020-2031
3.2.1 Global Inhalation Powder Budesonide Sales by Region: 2020-2025
3.2.2 Global Inhalation Powder Budesonide Sales by Region: 2026-2031
3.3 Global Inhalation Powder Budesonide Revenue by Region: 2020-2031
3.3.1 Global Inhalation Powder Budesonide Revenue by Region: 2020-2025
3.3.2 Global Inhalation Powder Budesonide Revenue by Region: 2026-2031
3.4 North America Inhalation Powder Budesonide Market Facts & Figures by Country
3.4.1 North America Inhalation Powder Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhalation Powder Budesonide Sales by Country (2020-2031)
3.4.3 North America Inhalation Powder Budesonide Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation Powder Budesonide Market Facts & Figures by Country
3.5.1 Europe Inhalation Powder Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhalation Powder Budesonide Sales by Country (2020-2031)
3.5.3 Europe Inhalation Powder Budesonide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation Powder Budesonide Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalation Powder Budesonide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhalation Powder Budesonide Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhalation Powder Budesonide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalation Powder Budesonide Market Facts & Figures by Country
3.7.1 Latin America Inhalation Powder Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhalation Powder Budesonide Sales by Country (2020-2031)
3.7.3 Latin America Inhalation Powder Budesonide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalation Powder Budesonide Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation Powder Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhalation Powder Budesonide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalation Powder Budesonide Sales by Type (2020-2031)
4.1.1 Global Inhalation Powder Budesonide Sales by Type (2020-2025)
4.1.2 Global Inhalation Powder Budesonide Sales by Type (2026-2031)
4.1.3 Global Inhalation Powder Budesonide Sales Market Share by Type (2020-2031)
4.2 Global Inhalation Powder Budesonide Revenue by Type (2020-2031)
4.2.1 Global Inhalation Powder Budesonide Revenue by Type (2020-2025)
4.2.2 Global Inhalation Powder Budesonide Revenue by Type (2026-2031)
4.2.3 Global Inhalation Powder Budesonide Revenue Market Share by Type (2020-2031)
4.3 Global Inhalation Powder Budesonide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhalation Powder Budesonide Sales by Application (2020-2031)
5.1.1 Global Inhalation Powder Budesonide Sales by Application (2020-2025)
5.1.2 Global Inhalation Powder Budesonide Sales by Application (2026-2031)
5.1.3 Global Inhalation Powder Budesonide Sales Market Share by Application (2020-2031)
5.2 Global Inhalation Powder Budesonide Revenue by Application (2020-2031)
5.2.1 Global Inhalation Powder Budesonide Revenue by Application (2020-2025)
5.2.2 Global Inhalation Powder Budesonide Revenue by Application (2026-2031)
5.2.3 Global Inhalation Powder Budesonide Revenue Market Share by Application (2020-2031)
5.3 Global Inhalation Powder Budesonide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Inhalation Powder Budesonide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Inhalation Powder Budesonide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Inhalation Powder Budesonide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sandoz Inhalation Powder Budesonide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Company Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cosmo Pharmaceuticals Inhalation Powder Budesonide Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Salix
6.6.1 Salix Company Information
6.6.2 Salix Description and Business Overview
6.6.3 Salix Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Salix Inhalation Powder Budesonide Product Portfolio
6.6.5 Salix Recent Developments/Updates
6.7 Chiesi Farmaceutici
6.7.1 Chiesi Farmaceutici Company Information
6.7.2 Chiesi Farmaceutici Description and Business Overview
6.7.3 Chiesi Farmaceutici Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chiesi Farmaceutici Inhalation Powder Budesonide Product Portfolio
6.7.5 Chiesi Farmaceutici Recent Developments/Updates
6.8 Orion Corporation
6.8.1 Orion Corporation Company Information
6.8.2 Orion Corporation Description and Business Overview
6.8.3 Orion Corporation Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Orion Corporation Inhalation Powder Budesonide Product Portfolio
6.8.5 Orion Corporation Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cipla Inhalation Powder Budesonide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Company Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Synmosa Biopharma Inhalation Powder Budesonide Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Company Information
6.11.2 Lunan Better Pharma Description and Business Overview
6.11.3 Lunan Better Pharma Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lunan Better Pharma Inhalation Powder Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments/Updates
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Company Information
6.12.2 Shanghai Sine Promod Description and Business Overview
6.12.3 Shanghai Sine Promod Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Sine Promod Inhalation Powder Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalation Powder Budesonide Industry Chain Analysis
7.2 Inhalation Powder Budesonide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation Powder Budesonide Production Mode & Process Analysis
7.4 Inhalation Powder Budesonide Sales and Marketing
7.4.1 Inhalation Powder Budesonide Sales Channels
7.4.2 Inhalation Powder Budesonide Distributors
7.5 Inhalation Powder Budesonide Customer Analysis
8 Inhalation Powder Budesonide Market Dynamics
8.1 Inhalation Powder Budesonide Industry Trends
8.2 Inhalation Powder Budesonide Market Drivers
8.3 Inhalation Powder Budesonide Market Challenges
8.4 Inhalation Powder Budesonide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
TEVA
Mylan NV
Sandoz Inc
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla Ltd
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
List of Tables
 Table 1. Global Inhalation Powder Budesonide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inhalation Powder Budesonide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inhalation Powder Budesonide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inhalation Powder Budesonide Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Inhalation Powder Budesonide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inhalation Powder Budesonide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inhalation Powder Budesonide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inhalation Powder Budesonide Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inhalation Powder Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inhalation Powder Budesonide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inhalation Powder Budesonide, Product Type & Application
 Table 12. Global Key Manufacturers of Inhalation Powder Budesonide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhalation Powder Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Powder Budesonide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhalation Powder Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inhalation Powder Budesonide Sales by Region (2020-2025) & (K Units)
 Table 18. Global Inhalation Powder Budesonide Sales Market Share by Region (2020-2025)
 Table 19. Global Inhalation Powder Budesonide Sales by Region (2026-2031) & (K Units)
 Table 20. Global Inhalation Powder Budesonide Sales Market Share by Region (2026-2031)
 Table 21. Global Inhalation Powder Budesonide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inhalation Powder Budesonide Revenue Market Share by Region (2020-2025)
 Table 23. Global Inhalation Powder Budesonide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inhalation Powder Budesonide Revenue Market Share by Region (2026-2031)
 Table 25. North America Inhalation Powder Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inhalation Powder Budesonide Sales by Country (2020-2025) & (K Units)
 Table 27. North America Inhalation Powder Budesonide Sales by Country (2026-2031) & (K Units)
 Table 28. North America Inhalation Powder Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inhalation Powder Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inhalation Powder Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inhalation Powder Budesonide Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Inhalation Powder Budesonide Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Inhalation Powder Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inhalation Powder Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inhalation Powder Budesonide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inhalation Powder Budesonide Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Inhalation Powder Budesonide Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Inhalation Powder Budesonide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inhalation Powder Budesonide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inhalation Powder Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inhalation Powder Budesonide Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Inhalation Powder Budesonide Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Inhalation Powder Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inhalation Powder Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inhalation Powder Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inhalation Powder Budesonide Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Inhalation Powder Budesonide Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inhalation Powder Budesonide Sales (K Units) by Type (2020-2025)
 Table 51. Global Inhalation Powder Budesonide Sales (K Units) by Type (2026-2031)
 Table 52. Global Inhalation Powder Budesonide Sales Market Share by Type (2020-2025)
 Table 53. Global Inhalation Powder Budesonide Sales Market Share by Type (2026-2031)
 Table 54. Global Inhalation Powder Budesonide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inhalation Powder Budesonide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inhalation Powder Budesonide Revenue Market Share by Type (2020-2025)
 Table 57. Global Inhalation Powder Budesonide Revenue Market Share by Type (2026-2031)
 Table 58. Global Inhalation Powder Budesonide Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Inhalation Powder Budesonide Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Inhalation Powder Budesonide Sales (K Units) by Application (2020-2025)
 Table 61. Global Inhalation Powder Budesonide Sales (K Units) by Application (2026-2031)
 Table 62. Global Inhalation Powder Budesonide Sales Market Share by Application (2020-2025)
 Table 63. Global Inhalation Powder Budesonide Sales Market Share by Application (2026-2031)
 Table 64. Global Inhalation Powder Budesonide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inhalation Powder Budesonide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inhalation Powder Budesonide Revenue Market Share by Application (2020-2025)
 Table 67. Global Inhalation Powder Budesonide Revenue Market Share by Application (2026-2031)
 Table 68. Global Inhalation Powder Budesonide Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Inhalation Powder Budesonide Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Inhalation Powder Budesonide Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Inhalation Powder Budesonide Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mylan Inhalation Powder Budesonide Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sandoz Inhalation Powder Budesonide Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. Cosmo Pharmaceuticals Company Information
 Table 91. Cosmo Pharmaceuticals Description and Business Overview
 Table 92. Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cosmo Pharmaceuticals Inhalation Powder Budesonide Product
 Table 94. Cosmo Pharmaceuticals Recent Developments/Updates
 Table 95. Salix Company Information
 Table 96. Salix Description and Business Overview
 Table 97. Salix Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Salix Inhalation Powder Budesonide Product
 Table 99. Salix Recent Developments/Updates
 Table 100. Chiesi Farmaceutici Company Information
 Table 101. Chiesi Farmaceutici Description and Business Overview
 Table 102. Chiesi Farmaceutici Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Chiesi Farmaceutici Inhalation Powder Budesonide Product
 Table 104. Chiesi Farmaceutici Recent Developments/Updates
 Table 105. Orion Corporation Company Information
 Table 106. Orion Corporation Description and Business Overview
 Table 107. Orion Corporation Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Orion Corporation Inhalation Powder Budesonide Product
 Table 109. Orion Corporation Recent Developments/Updates
 Table 110. Cipla Company Information
 Table 111. Cipla Description and Business Overview
 Table 112. Cipla Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cipla Inhalation Powder Budesonide Product
 Table 114. Cipla Recent Developments/Updates
 Table 115. Synmosa Biopharma Company Information
 Table 116. Synmosa Biopharma Description and Business Overview
 Table 117. Synmosa Biopharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Synmosa Biopharma Inhalation Powder Budesonide Product
 Table 119. Synmosa Biopharma Recent Developments/Updates
 Table 120. Lunan Better Pharma Company Information
 Table 121. Lunan Better Pharma Description and Business Overview
 Table 122. Lunan Better Pharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Lunan Better Pharma Inhalation Powder Budesonide Product
 Table 124. Lunan Better Pharma Recent Developments/Updates
 Table 125. Shanghai Sine Promod Company Information
 Table 126. Shanghai Sine Promod Description and Business Overview
 Table 127. Shanghai Sine Promod Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shanghai Sine Promod Inhalation Powder Budesonide Product
 Table 129. Shanghai Sine Promod Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Inhalation Powder Budesonide Distributors List
 Table 133. Inhalation Powder Budesonide Customers List
 Table 134. Inhalation Powder Budesonide Market Trends
 Table 135. Inhalation Powder Budesonide Market Drivers
 Table 136. Inhalation Powder Budesonide Market Challenges
 Table 137. Inhalation Powder Budesonide Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhalation Powder Budesonide
 Figure 2. Global Inhalation Powder Budesonide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inhalation Powder Budesonide Market Share by Type: 2024 & 2031
 Figure 4. 100~200 Inhalation Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Inhalation Powder Budesonide Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Inhalation Powder Budesonide Market Share by Application: 2024 & 2031
 Figure 8. Respiratory Disease Treatment
 Figure 9. Nose Disease Treatment
 Figure 10. Inflammatory Bowel Disease Treatment
 Figure 11. Other
 Figure 12. Global Inhalation Powder Budesonide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Inhalation Powder Budesonide Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Inhalation Powder Budesonide Sales (2020-2031) & (K Units)
 Figure 15. Global Inhalation Powder Budesonide Average Price (US$/Unit) & (2020-2031)
 Figure 16. Inhalation Powder Budesonide Report Years Considered
 Figure 17. Inhalation Powder Budesonide Sales Share by Manufacturers in 2024
 Figure 18. Global Inhalation Powder Budesonide Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Inhalation Powder Budesonide Players: Market Share by Revenue in Inhalation Powder Budesonide in 2024
 Figure 20. Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Inhalation Powder Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Inhalation Powder Budesonide Sales Market Share by Country (2020-2031)
 Figure 23. North America Inhalation Powder Budesonide Revenue Market Share by Country (2020-2031)
 Figure 24. United States Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Inhalation Powder Budesonide Sales Market Share by Country (2020-2031)
 Figure 27. Europe Inhalation Powder Budesonide Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Inhalation Powder Budesonide Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Inhalation Powder Budesonide Revenue Market Share by Region (2020-2031)
 Figure 35. China Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Inhalation Powder Budesonide Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Inhalation Powder Budesonide Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Inhalation Powder Budesonide Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Inhalation Powder Budesonide Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Inhalation Powder Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Inhalation Powder Budesonide by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Inhalation Powder Budesonide by Type (2020-2031)
 Figure 56. Global Inhalation Powder Budesonide Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Inhalation Powder Budesonide by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Inhalation Powder Budesonide by Application (2020-2031)
 Figure 59. Global Inhalation Powder Budesonide Price (US$/Unit) by Application (2020-2031)
 Figure 60. Inhalation Powder Budesonide Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Budesonide and Formoterol Powder Inhalation Market Research Report 2024
Global Budesonide Market Research Report 2025
Global Budesonide Inhaler Market Research Report 2024
Aerosols Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Budesonide and Formoterol Inhalation Market Research Report 2024
Tablet and Capsule Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Suspension Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Corticosteroids Inhalation Formulation Market Research Report 2024
Budesonide Aerosol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dry Powder Inhalation Delivery System Market Research Report 2024
Nebulized Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nebulized Inhaled Drug Market Research Report 2024
Global Inhalation Drug Delivery Devices Market Research Report 2024
Drug Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Asthma Inhalation Formulation Market Research Report 2024
Global Dry Powder Inhalation Medication Market Research Report 2024
Global Inhalation Therapy Nebuliser Market Research Report 2024
Salbutamol Inhalation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dry Powder Inhalation Device Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions